This proposal focuses on the mechanisms of integrin activation, which is crucial for basic cellular responses essential for normal physiology and pathologies ranging from thrombosis, inflammation, and vascular dysfunction. Integrins play a key role in angiogenesis, or the formation of new blood vessels from existing vasculature. There is a need to understand how angiogenesis is regulated so that innovative approaches for the control of excessive vascular growth in patients with distinct therapeutic needs (i.e. cancer, age-related macular degeneration and retinopathy of diabetes) can be identified. Our mechanistic focus is on Kindlins, a novel family of intracellular mediators which are required for integrin functions on all cells. Although our previous and preliminary studies demonstrated importance of Kindlins in human pathologies, many Kindlins' functions remain to be identified. Thus, the goal of this project is to further understand the molecular mechanisms and structural requirements underlying integrin-dependent and independent functions of kindlins in endothelial and myeloid cells during vascularization processes. The main hypothesis to be tested is that K3 is required for functions of endothelial and myeloid cells in angiogenesis and many, but not all, of these functions are integrin-dependent. The following Aims are proposed:
Aim 1. To determine whether K3- dependent regulation of integrins in endothelial and myeloid cells plays a critical role in vascularization in vivo. We will test the hypothesis that K3-integrin interaction is crucial for the regulation of angiogenesis in vivo by using newly generated K3KI knockin mice (expressing a mutant of K3 that is unable to bind to integrin). We will compare the role for K3 on endothelial to that on myeloid cells.
Aim 2. To assess the mechanisms responsible for impaired function of endothelial and myeloid cells from K3KI mice, and perform rescue experiments with K3 and K2. To determine the structural requirement for K3-specific functions in EC.
Aim 3. To determine whether and how K3 function in hematopoietic cells is regulated during integrin activation with an emphasis on the regulatory role of K3 phosphorylation.

Public Health Relevance

The goal of this project is to further understand the functions of kindlins as main integrin regulators in endothelial and myeloid cells during angiogenesis. Integrins are essential for the survival and function of most organisms, from protozoa to humans. Integrins and their activation is a key event in thrombosis, inflammation, vascular organization and development as well as vascular diseases. Abnormalities in integrin expression or function lead to severe diseases in humans. We will assess how integrin activity is regulated during developmental and pathological vascularization and will define the mechanisms of this process. We will focus on one of the least understood cell types, microglia, in the eye. These cells are actively involved in organization of vascular architecture but the mechanisms and the precise function are not understood. Together, these studies will advance our understanding of severe human diseases associated with integrin or kindlin deficiencies and will help with immediate treatment of these patients. We will uncover the mechanisms controlling angiogenesis in retinas and other tissues to identify novel therapeutic targets for vascular complications, i.e. macular degeneration, retinopathy of diabetes, cancer and ischemic disorders.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL073311-14
Application #
9469561
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Sarkar, Rita
Project Start
2004-04-15
Project End
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
14
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Szpak, Dorota; Izem, Lahoucine; Verbovetskiy, Dmitriy et al. (2018) ?M?2 Is Antiatherogenic in Female but Not Male Mice. J Immunol 200:2426-2438
Plow, Edward F; Wang, Yunmei; Simon, Daniel I (2018) The search for new antithrombotic mechanisms and therapies that may spare hemostasis. Blood 131:1899-1902
Sossey-Alaoui, Khalid; Pluskota, Elzbieta; Szpak, Dorota et al. (2018) The Kindlin-2 regulation of epithelial-to-mesenchymal transition in breast cancer metastasis is mediated through miR-200b. Sci Rep 8:7360
Gao, Detao; Podrez, Eugene A (2018) Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids. Free Radic Biol Med 115:57-67
Wang, Yunmei; Gao, Huiyun; Shi, Can et al. (2017) Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIb?. Nat Commun 8:15559
Meller, Julia; Chen, Zhihong; Dudiki, Tejasvi et al. (2017) Integrin-Kindlin3 requirements for microglial motility in vivo are distinct from those for macrophages. JCI Insight 2:
Hirbawi, Jamila; Bialkowska, Katarzyna; Bledzka, Kamila M et al. (2017) The extreme C-terminal region of kindlin-2 is critical to its regulation of integrin activation. J Biol Chem 292:14258-14269
Ithychanda, Sujay S; Dou, Kevin; Robertson, Stephen P et al. (2017) Structural and thermodynamic basis of a frontometaphyseal dysplasia mutation in filamin A. J Biol Chem 292:8390-8400
Feng, Weiyi; Valiyaveettil, Manojkumar; Dudiki, Tejasvi et al. (2017) ?3 phosphorylation of platelet ?IIb?3 is crucial for stability of arterial thrombus and microparticle formation in vivo. Thromb J 15:22
Plow, Edward F (2017) An enlightening year in vascular biology. Curr Opin Hematol 24:222-223

Showing the most recent 10 out of 105 publications